H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Sutro Biopharma (STRO – Research Report) today and set a price target of $12.00. Andrew Fein has given his Buy rating due to a ...

JMP Securities analyst Reni Benjamin reiterated a Buy rating on Sutro Biopharma (STRO – Research Report) today and set a price target of $17.00. Reni Benjamin has given his Buy rating due to a ...

Bill Miles, CEO of Miles Construction in Carson City, shone his flashlight into the Sutro Tunnel on Sept. 12 to show its improvement and potential for cleanup and restoration. “We’re going to try to ...

In the last three months, 4 analysts have published ratings on Sutro Biopharma (NASDAQ:STRO), offering a diverse range of perspectives from bullish to bearish. The following table encapsulates ...

Redeem big savings by browsing best-sellers and new arrivals with Oakley discount codes. You will never miss another sale when you shop with our help.

Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates ...

Follow live coverage as Lens face Olympique Lyonnais in Ligue 1 today. While PSG have dominated domestically in France’s top flight over the past few years, they have yet to replicate their ...

In this article, we are going to take a look at where Realty Income Corporation (NYSE:O) stands against the other good stocks to buy for passive income. With rising costs in today’s world ...

Executive Editor David Carnoy has been a leading member of CNET's Reviews team since 2000. He covers the gamut of gadgets and is a notable reviewer of mobile accessories and portable audio ...

Sept. 14, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates ...